| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $18.8M | -15.0% |
| SG&A Expense | $23.6M | +28.8% |
| Operating Income | -$39.2M | +4.4% |
| Income Tax | $0 | — |
| Net Income | -$27.0M | +29.9% |
| EPS (Basic) | -$3.31 | +67.4% |
| EPS (Diluted) | -$3.31 | +67.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.6M | -85.2% |
| Current Assets | $9.5M | -82.0% |
| Total Assets | $9.5M | -82.9% |
| Current Liabilities | $2.5M | -85.3% |
| Long-term Debt | $29.3M | +0.0% |
| Total Liabilities | $2.5M | -94.2% |
| Stockholders' Equity | $7.0M | -43.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.0M | -8.9% |
| Investing Cash Flow | -$15K | +92.8% |
| Financing Cash Flow | -$11.6M | -138.9% |